{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:40:33Z","timestamp":1791042033106,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,2,2]],"date-time":"2009-02-02T00:00:00Z","timestamp":1233532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,2,2]],"date-time":"2009-02-02T00:00:00Z","timestamp":1233532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2009,3,19]]},"DOI":"10.1038\/onc.2008.492","type":"journal-article","created":{"date-parts":[[2009,2,2]],"date-time":"2009-02-02T11:23:10Z","timestamp":1233573790000},"page":"1471-1476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Epstein\u2013Barr virus LMP2A accelerates MYC-induced lymphomagenesis"],"prefix":"10.1038","volume":"28","author":[{"given":"R","family":"Bultema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Longnecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Swanson-Mungerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,2]]},"reference":[{"key":"BFonc2008492_CR1","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1099\/vir.0.2008\/001461-0","volume":"89","author":"LJ Anderson","year":"2008","unstructured":"Anderson LJ, Longnecker R . (2008). EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK\/MAPK pathway. J Gen Virol 89: 1563\u20131568.","journal-title":"J Gen Virol"},{"key":"BFonc2008492_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","volume":"13","author":"GJ Babcock","year":"2000","unstructured":"Babcock GJ, Hochberg D, Thorley-Lawson AD . (2000). The expression pattern of Epstein\u2013Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13: 497\u2013506.","journal-title":"Immunity"},{"key":"BFonc2008492_CR3","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1099\/vir.0.81906-0","volume":"87","author":"AI Bell","year":"2006","unstructured":"Bell AI, Groves K, Kelly GL, Croom-Carter D, Hui E, Chan AT et al. (2006). Analysis of Epstein\u2013Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J Gen Virol 87: 2885\u20132890.","journal-title":"J Gen Virol"},{"key":"BFonc2008492_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","volume":"9","author":"RG Caldwell","year":"1998","unstructured":"Caldwell RG, Wilson JB, Anderson SJ, Longnecker R . (1998). Epstein\u2013Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9: 405\u2013411.","journal-title":"Immunity"},{"key":"BFonc2008492_CR5","doi-asserted-by":"publisher","first-page":"9556","DOI":"10.1128\/JVI.76.18.9556-9561.2002","volume":"76","author":"SY Chen","year":"2002","unstructured":"Chen SY, Lu J, Shih YC, Tsai CH . (2002). Epstein\u2013Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase. J Virol 76: 9556\u20139561.","journal-title":"J Virol"},{"key":"BFonc2008492_CR6","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","volume":"79","author":"R Dalla-Favera","year":"1982","unstructured":"Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM . (1982). Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79: 7824\u20137827.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2008492_CR7","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.1073\/pnas.0401471101","volume":"101","author":"A Egle","year":"2004","unstructured":"Egle A, Harris AW, Bouillet P, Cory S . (2004). Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci USA 101: 6164\u20136169.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2008492_CR8","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1128\/MCB.21.15.5063-5070.2001","volume":"21","author":"CM Eischen","year":"2001","unstructured":"Eischen CM, Woo D, Roussel MF, Cleveland JL . (2001). Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Mol Cell Biol 21: 5063\u20135070.","journal-title":"Mol Cell Biol"},{"key":"BFonc2008492_CR9","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Achong BG, Barr YM . (1964). Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1: 702\u2013703.","journal-title":"Lancet"},{"key":"BFonc2008492_CR10","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1128\/JVI.78.4.1697-1705.2004","volume":"78","author":"M Fukuda","year":"2004","unstructured":"Fukuda M, Longnecker R . (2004). Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase\/Akt pathway. J Virol 78: 1697\u20131705.","journal-title":"J Virol"},{"key":"BFonc2008492_CR11","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1128\/MCB.00907-07","volume":"28","author":"SP Garrison","year":"2008","unstructured":"Garrison SP, Jeffers JR, Yang C, Nilsson JA, Hall MA, Rehg JE et al. (2008). Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol Cell Biol 28: 5391\u20135402.","journal-title":"Mol Cell Biol"},{"key":"BFonc2008492_CR12","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/sj.onc.1202468","volume":"18","author":"A Gerbitz","year":"1999","unstructured":"Gerbitz A, Mautner J, Geltinger C, Hortnagel K, Christoph B, Asenbauer H et al. (1999). Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma. Oncogene 18: 1745\u20131753.","journal-title":"Oncogene"},{"key":"BFonc2008492_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1084\/jem.167.2.353","volume":"167","author":"AW Harris","year":"1988","unstructured":"Harris AW, Pinkert CA, Crawford M, Langdon WY, Brinster RL, Adams JM . (1988). The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J Exp Med 167: 353\u2013371.","journal-title":"J Exp Med"},{"key":"BFonc2008492_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nature03845","volume":"436","author":"MT Hemann","year":"2005","unstructured":"Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C et al. (2005). Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 436: 807\u2013811.","journal-title":"Nature"},{"key":"BFonc2008492_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1040-8428(00)00046-9","volume":"34","author":"JL Hsu","year":"2000","unstructured":"Hsu JL, Glaser SL . (2000). Epstein\u2013Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol 34: 27\u201353.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFonc2008492_CR16","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.4049\/jimmunol.172.9.5329","volume":"172","author":"A Ikeda","year":"2004","unstructured":"Ikeda A, Merchant M, Lev L, Longnecker R, Ikeda M . (2004). Latent membrane protein 2A, a viral B cell receptor homologue, induces CD5+ B-1 cell development. J Immunol 172: 5329\u20135337.","journal-title":"J Immunol"},{"key":"BFonc2008492_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/path.1940","volume":"209","author":"JS Kim","year":"2006","unstructured":"Kim JS, Han SS, Park SS, McNeil N, Janz S . (2006). Plasma cell tumour progression in iMycEmu gene-insertion mice. J Pathol 209: 44\u201355.","journal-title":"J Pathol"},{"key":"BFonc2008492_CR18","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1084\/jem.192.8.1183","volume":"192","author":"AL Kovalchuk","year":"2000","unstructured":"Kovalchuk AL, Qi CF, Torrey TA, Taddesse-Heath L, Feigenbaum L, Park SS et al. (2000). Burkitt lymphoma in the mouse. J Exp Med 192: 1183\u20131190.","journal-title":"J Exp Med"},{"key":"BFonc2008492_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1074-7613(00)00048-0","volume":"13","author":"J Kurth","year":"2000","unstructured":"Kurth J, Spieker T, Wustrow J, Strickler GJ, Hansmann LM, Rajewsky K et al. (2000). EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity 13: 485\u2013495.","journal-title":"Immunity"},{"key":"BFonc2008492_CR20","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1182\/blood-2003-10-3399","volume":"103","author":"M Linden","year":"2004","unstructured":"Linden M, Kirchhof N, Carlson C, Van Ness B . (2004). Targeted overexpression of Bcl-XL in B-lymphoid cells results in lymphoproliferative disease and plasma cell malignancies. Blood 103: 2779\u20132786.","journal-title":"Blood"},{"key":"BFonc2008492_CR21","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1182\/blood-2005-06-2341","volume":"106","author":"C Mancao","year":"2005","unstructured":"Mancao C, Altmann M, Jungnickel B, Hammerschmidt W . (2005). Rescue of \u2018crippled\u2019 germinal center B cells from apoptosis by Epstein\u2013Barr virus. Blood 106: 4339\u20134344.","journal-title":"Blood"},{"key":"BFonc2008492_CR22","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","volume":"110","author":"C Mancao","year":"2007","unstructured":"Mancao C, Hammerschmidt W . (2007). Epstein\u2013Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood 110: 3715\u20133721.","journal-title":"Blood"},{"key":"BFonc2008492_CR23","volume-title":"Biostatistical Methods in Epidemiology","author":"SC Newman","year":"2003","unstructured":"Newman SC . (2003). Biostatistical Methods in Epidemiology. John Wiley and Sons Inc.: New York, NY."},{"key":"BFonc2008492_CR24","doi-asserted-by":"publisher","first-page":"9007","DOI":"10.1038\/sj.onc.1207261","volume":"22","author":"JA Nilsson","year":"2003","unstructured":"Nilsson JA, Cleveland JL . (2003). Myc pathways provoking cell suicide and cancer. Oncogene 22: 9007\u20139021.","journal-title":"Oncogene"},{"key":"BFonc2008492_CR25","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1111\/j.1462-5822.2008.01221.x","volume":"10","author":"YR Pan","year":"2008","unstructured":"Pan YR, Vatsyayan J, Chang YS, Chang HY . (2008). Epstein\u2013Barr virus latent membrane protein 2A upregulates UDP-glucose dehydrogenase gene expression via ERK and PI3K\/Akt pathway. Cell Microbiol 10: 2447\u20132460.","journal-title":"Cell Microbiol"},{"key":"BFonc2008492_CR26","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1128\/jvi.71.6.4752-4760.1997","volume":"71","author":"CG Panousis","year":"1997","unstructured":"Panousis CG, Rowe DT . (1997). Epstein\u2013Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase. J Virol 71: 4752\u20134760.","journal-title":"J Virol"},{"key":"BFonc2008492_CR27","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1158\/0008-5472.CAN-04-0268","volume":"65","author":"SS Park","year":"2005","unstructured":"Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS et al. (2005). Insertion of c-Myc into IgH induces B-cell and plasma-cell neoplasms in mice. Cancer Res 65: 1306\u20131315.","journal-title":"Cancer Res"},{"key":"BFonc2008492_CR28","doi-asserted-by":"publisher","first-page":"8619","DOI":"10.1038\/sj.onc.1207905","volume":"23","author":"T Portis","year":"2004","unstructured":"Portis T, Longnecker R . (2004). Epstein\u2013Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras\/PI3K\/AKT pathway. Oncogene 23: 8619\u20138628.","journal-title":"Oncogene"},{"key":"BFonc2008492_CR29","volume-title":"Epstein\u2013Barr Virus","author":"ABaEK Rickinson","year":"2007","unstructured":"Rickinson ABaEK . (2007). Epstein\u2013Barr Virus. Lippincott-Raven Publishers II: Philadelphia, PA."},{"key":"BFonc2008492_CR30","doi-asserted-by":"publisher","first-page":"6684","DOI":"10.4049\/jimmunol.172.11.6684","volume":"172","author":"PJ Swanson","year":"2004","unstructured":"Swanson PJ, Kuslak SL, Fang W, Tze L, Gaffney P, Selby S et al. (2004). Fatal acute lymphoblastic leukemia in mice transgenic for B cell-restricted bcl-xL and c-myc. J Immunol 172: 6684\u20136691.","journal-title":"J Immunol"},{"key":"BFonc2008492_CR31","doi-asserted-by":"publisher","first-page":"6764","DOI":"10.1128\/JVI.00433-06","volume":"80","author":"M Swanson-Mungerson","year":"2006","unstructured":"Swanson-Mungerson M, Bultema R, Longnecker R . (2006). Epstein\u2013Barr virus LMP2A enhances B-cell responses in vivo and in vitro. J Virol 80: 6764\u20136770.","journal-title":"J Virol"},{"key":"BFonc2008492_CR32","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1128\/JVI.79.12.7355-7362.2005","volume":"79","author":"MA Swanson-Mungerson","year":"2005","unstructured":"Swanson-Mungerson MA, Caldwell RG, Bultema R, Longnecker R . (2005). Epstein\u2013Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen. J Virol 79: 7355\u20137362.","journal-title":"J Virol"},{"key":"BFonc2008492_CR33","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V91.4.1373","volume":"91","author":"Q Tao","year":"1998","unstructured":"Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF . (1998). Epstein\u2013Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 91: 1373\u20131381.","journal-title":"Blood"},{"key":"BFonc2008492_CR34","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1073\/pnas.79.24.7837","volume":"79","author":"R Taub","year":"1982","unstructured":"Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S et al. (1982). Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA 79: 7837\u20137841.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2008492_CR35","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMra032015","volume":"350","author":"DA Thorley-Lawson","year":"2004","unstructured":"Thorley-Lawson DA, Gross A . (2004). Persistence of the Epstein\u2013Barr virus and the origins of associated lymphomas. N Engl J Med 350: 1328\u20131337.","journal-title":"N Engl J Med"},{"key":"BFonc2008492_CR36","doi-asserted-by":"publisher","first-page":"34725","DOI":"10.1074\/jbc.R600017200","volume":"281","author":"J Vervoorts","year":"2006","unstructured":"Vervoorts J, Luscher-Firzlaff J, Luscher B . (2006). The ins and outs of MYC regulation by posttranslational mechanisms. J Biol Chem 281: 34725\u201334729.","journal-title":"J Biol Chem"},{"key":"BFonc2008492_CR37","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.4049\/jimmunol.177.5.2793","volume":"177","author":"H Wang","year":"2006","unstructured":"Wang H, Nicholas MW, Conway KL, Sen P, Diz R, Tisch RM et al. (2006). EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol 177: 2793\u20132802.","journal-title":"J Immunol"},{"key":"BFonc2008492_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrm2308","volume":"9","author":"RJ Youle","year":"2008","unstructured":"Youle RJ, Strasser A . (2008). The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47\u201359.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2008492_CR39","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1182\/blood-2004-07-2573","volume":"105","author":"D Zhu","year":"2005","unstructured":"Zhu D, Qi CF, Morse III HC, Janz S, Stevenson FK . (2005). Deregulated expression of the Myc cellular oncogene drives development of mouse \u2018Burkitt-like\u2019 lymphomas from naive B cells. Blood 105: 2135\u20132137.","journal-title":"Blood"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2008492.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2008492","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2008492.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T16:34:52Z","timestamp":1647880492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2008492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,2]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,3,19]]}},"alternative-id":["BFonc2008492"],"URL":"https:\/\/doi.org\/10.1038\/onc.2008.492","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,2]]},"assertion":[{"value":"10 July 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}